Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Tag Archives: EU
IP negotiations at the UN High-Level Meeting on HIV/AIDS
UN High Level Meeting on HIV/AIDS is set to take place from 8–10 June 2011 in New York to review progress and chart the future course of the global AIDS response. Member States are expected to adopt a new Declaration … Continue reading
Posted in HIV/Aids, TRIPS, TRIPS plus, UN General Assembly HLM
Tagged EU, FTAs, GFATM funding, HIV treatment targets, HIV/Aids, Intellectual property, TRIPS, TRIPS flexibilities, UNGASS
3 Comments
Press: Free trade pact with four European nations this year
Source: The Hindu, 25.3.2011, by Sujay Mehdudia India and the Europe Free Trade Association (EFTA) are likely to conclude a free trade agreement (FTA) entailing a comprehensive bilateral trade and investment agreement by this year after fast tracking of the … Continue reading
Press: Proposed FTA to raise HIV/AIDS drug prices
Source: IBN live, 8.3.2011, by Ginny Narula Click here to watch the video New Delhi: People people living with HIV/AIDS want to send the government a strong message. More than four lakh people on life-saving anti-retroviral drugs in India could … Continue reading
Take Action: Global E-Protest against FTAs
Write to members of Indian governement and European Commission to save affordable medicines and access to life-saving treatments in Africa, Asia and Latin America ! The reasons why we must protest For months now, activists around the world have been … Continue reading
Press: Civil Society Defends Access to Generic Drugs
Source: IPS News, 28.2.2011, Miriam Gathigah NAIROBI, Feb 28, 2011 (IPS) – Access to affordable medicine for millions of people in the South could be at risk if the production and distribution of generic medicine from India is restricted. Campaigners … Continue reading
Press: ‘FTA with EU will kill HIV patients’
Source: Free Malaysia Today, 28.2.2011, by Patrick Lee Prices of medicine will be beyond reach to many once talks are concluded and they are likely to die as a result. KUALA LUMPUR: A Free Trade Agreement (FTA) with the European … Continue reading
Protest rally against EU-India FTA on 2nd of March
MEDIA ADVISORY: WEDNESDAY, 2 MARCH 2011 RALLY – 10am, Ramlila Ground to Jantar Mantar, Delhi PRESS CONFERENCE – 2 pm, Foreign Correspondents’ Club HIV+ People From Across India and Asia Say – “DON’T TRADE AWAY OUR LIVES” – in the … Continue reading
Press: Africa’s Aids patients biggest losers if India/EU drugs deal sails through
Source: The East African, 28.2.2011, by Jeff Otieno Jimmy Gideyi has been on free antiretroviral generic drugs manufactured in India since 2004, when he was confirmed HIV positive. In the past decade, the 56-year-old man has received a constant supply … Continue reading
Posted in EU-India FTA
Tagged Compulsory license, EU, FTA, Generic drug, HIV/Aids, India, Karel de Gucht, Médecins Sans Frontières
Leave a comment
Press: EU’s pharma trade hoax
Source: The Hindu Business Line, 25.2.2011, by Tahir Amin/Priti Radhakrishnan The proposed India-EU trade pact is riddled with intellectual property provisions that would harm India’s 2005 Patent Act. Last month, the global health community cheered when India’s patent office ruled … Continue reading
Posted in EU-India FTA
Tagged EU, FTA, Generic drug, HIV/Aids, India, Intellectual property, TRIPS
Leave a comment
Press: Monopoly on pesticide test data set to be extended to 5 years
Source: Economic Times, 24.2.2011 NEW DELHI: The government has proposed an increase in the monopoly period enjoyed by pesticide manufacturers over test data , used to support claims for the efficacy of their products, to five years. The proposals form … Continue reading
Posted in EU-India FTA
Tagged EU, FTA, Generic drug, India, Médecins Sans Frontières
Leave a comment
